Antonio Bordunovi/iStock Editorial via Getty Images Nvidia ( NVDA ) is looking to extend its artificial intelligence dominance beyond data centers and into personal computers, unveiling a new N1X processor and RTX Spark superchip designed to power the next generation of AI-focused Windows PCs. During a keynote address at Taiwan's Computex conference on Monday, CEO Jensen Huang introduced the N1X p...
Antonio Bordunovi/iStock Editorial via Getty Images Nvidia ( NVDA ) is looking to extend its artificial intelligence dominance beyond data centers and into personal computers, unveiling a new N1X processor and RTX Spark superchip designed to power the next generation of AI-focused Windows PCs. During a keynote address at Taiwan's Computex conference on Monday, CEO Jensen Huang introduced the N1X processor, developed in collaboration with Microsoft ( MSFT ). The chip will be integrated into Nvidia's RTX Spark superchip, which is set to debut this fall in a new lineup of Windows PCs from Microsoft, Dell Technologies ( DELL ), HP Inc. ( HPQ ), ASUS, Lenovo ( LNVGY ) ( LNVGF ), and MSI. The move positions Nvidia against established PC chipmakers Intel ( INTC ), Advanced Micro Devices ( AMD ), Qualcomm ( QCOM ) and Apple ( AAPL ), while potentially boosting demand for memory, storage, networking, and PC hardware providers across the emerging AI PC ecosystem. Against this backdrop, here's how companies across the AI PC ecosystem stack up based on Seeking Alpha Quant Ratings, valuation grades, and year-to-date performance. Potential Beneficiaries Micron Technology ( MU ): Quant Rating 4.99 (Strong Buy); Valuation Grade B+; +240.21% YTD Sandisk ( SNDK ): Quant Rating 4.99 (Strong Buy); Valuation Grade A+; +614% YTD Dell Technologies ( DELL ): Quant Rating 3.49 (Hold); Valuation Grade F; +234.37% YTD Western Digital ( WDC ): Quant Rating 3.49 (Hold); Valuation Grade F; +208.36% YTD Seagate Technology ( STX ): Quant Rating 3.49 (Hold); Valuation Grade F; +219.47% YTD Microsoft ( MSFT ): Quant Rating 3.46 (Hold); Valuation Grade F; -6.90% YTD HP Inc. ( HPQ ): Quant Rating 3.15 (Hold); Valuation Grade A; +21.36% YTD Hewlett Packard Enterprise ( HPE ): Quant Rating 4.90 (Strong Buy); Valuation Grade C; +79.18% YTD Samsung Electronics ( SSNLF ) SK Hynix ( HXSCL ) Incumbents Facing New Competition Intel ( INTC ): Quant Rating 4.99 (Strong Buy); Valuation Grade D+; +210.79% YTD Adv...
A cyclist was seriously injured after being struck by a KMB double-decker bus in Hong Kong on Monday afternoon. The 60-year-old man was hit at around 2.50pm outside North Kwai Chung Public Library on Shek Yam Road. He was trapped beneath the front wheels of the bus and had to be freed by firefighters and paramedics. He was rushed unconscious to Yan Chai Hospital in Tsuen Wan. Images from the scene...
A cyclist was seriously injured after being struck by a KMB double-decker bus in Hong Kong on Monday afternoon. The 60-year-old man was hit at around 2.50pm outside North Kwai Chung Public Library on Shek Yam Road. He was trapped beneath the front wheels of the bus and had to be freed by firefighters and paramedics. He was rushed unconscious to Yan Chai Hospital in Tsuen Wan. Images from the scene showed the man’s lower body pinned under the bus, with a long skid mark on the road. The bus...
NVIDIA (NASDAQ:NVDA) revealed that Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) is deploying a range of its artificial intelligence and accelerated computing technologies throughout semiconductor development and manufacturing processes, deepening the partnership between the two companies.
NVIDIA (NASDAQ:NVDA) revealed that Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) is deploying a range of its artificial intelligence and accelerated computing technologies throughout semiconductor development and manufacturing processes, deepening the partnership between the two companies.
A Philippine senator said he will surrender to authorities after a special anti-corruption court ordered his arrest on Monday on a non-bailable charge of plunder after he allegedly pocketed a huge kickback in a flood-control project in the latest crisis to hit the upper chamber. The special Sandiganbayan anti-corruption court had initially issued a warrant for Senator Jinggoy Estrada’s arrest on F...
A Philippine senator said he will surrender to authorities after a special anti-corruption court ordered his arrest on Monday on a non-bailable charge of plunder after he allegedly pocketed a huge kickback in a flood-control project in the latest crisis to hit the upper chamber. The special Sandiganbayan anti-corruption court had initially issued a warrant for Senator Jinggoy Estrada’s arrest on Friday on a corruption charge that was bailable. He then surrendered and was released on bail and...
The Liushenyu coal mine in Qinyuan county, Shanxi province, on May 23. Photo: IC Photo A deadly gas explosion at a mine in northern China has revealed an underground system of illegal labor and off-the-books coal sales, underscoring persistent enforcement gaps in the country’s largest coal-producing region. The blast on May 22 at the Liushenyu mine in Shanxi province killed at least 82 people and ...
The Liushenyu coal mine in Qinyuan county, Shanxi province, on May 23. Photo: IC Photo A deadly gas explosion at a mine in northern China has revealed an underground system of illegal labor and off-the-books coal sales, underscoring persistent enforcement gaps in the country’s largest coal-producing region. The blast on May 22 at the Liushenyu mine in Shanxi province killed at least 82 people and injured more than 120, making it the country’s deadliest coal-mine gas incident in more than a decade.
JOSE LUIS CALVO MARTIN & JOSE ENRIQUE GARCIA-MAURIÑO MUZQUIZ/iStock via Getty Images EQUITY RESEARCH | SPECIALTY PHARMACEUTICALS Grace Therapeutics, Inc. ( GRCE ) Initiating Coverage Item Value Rating SPECULATIVE BUY Price Target $4.00 (scenario-weighted) Current Price $2.54 Implied Upside +57% Strategy Bucket Crisis Alpha, Event-Driven Post CRL Click to enlarge Data by YCharts I. Executive Summar...
JOSE LUIS CALVO MARTIN & JOSE ENRIQUE GARCIA-MAURIÑO MUZQUIZ/iStock via Getty Images EQUITY RESEARCH | SPECIALTY PHARMACEUTICALS Grace Therapeutics, Inc. ( GRCE ) Initiating Coverage Item Value Rating SPECULATIVE BUY Price Target $4.00 (scenario-weighted) Current Price $2.54 Implied Upside +57% Strategy Bucket Crisis Alpha, Event-Driven Post CRL Click to enlarge Data by YCharts I. Executive Summary Pricing a Clinical Failure That Didn't Happen Grace Therapeutics dropped 45% recently after the FDA issued a CRL for GTx-104, its intravenous formulation for treating aneurysmal subarachnoid hemorrhage (aSAH). The stock has now been rebounding for the past few days. The market seems to be pricing in total failure of this product candidate, but the FDA only raised fixable issues related to Chemistry, Manufacturing, and Controls (CMC), like leachables data for product packaging, non-clinical toxicology risk assessments, and manufacturing concerns at the contract manufacturer, and did not raise any concerns about efficacy or safety. The company is requesting a Type A meeting with the FDA to discuss CRL issues. Based on the historical data about CMC-related CRLs and unmet need in SAH, we assign a 75% probability that the repeat New Drug Application (NDA) will be accepted. Based on scenario-weighted discounted cash flow valuation, we assign a $4 price target or 57% upside. II. The Asset: GTx-104 Fulfilling An Unmet Need Nimodipine, a vasodilator, is used in aSAH patients to prevent delayed cerebral ischemia due to vasospasm. The oral version of this drug has poor bioavailability, and only 3-30% of it is absorbed in aSAH patients. It also has poor compliance in the real world, and only 17% of patients received the scheduled doses in a series. Poor compliance is associated with delayed discharge to home. Intravenous formulations of nimodipine are available in countries like the EU, the UK, China, etc. However, the FDA has not approved this formulation (Nimotop) for use internati...